Evidence map›Paper›PMID 31875854›Full record

ArticleNature2020

H2A.Z facilitates licensing and activation of early replication origins.

Haizhen Long, Liwei Zhang, Mengjie Lv, Zengqi Wen, Wenhao Zhang, Xiulan Chen, Peitao Zhang, Tongqing Li, Luyuan Chang, Caiwei Jin and 9 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Nature, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 118 papers.

0numbers the graph read from it
0cells of the map it votes in
118citing papers in PubMed
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

118 citing papers in PubMed, 181 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Ferroptosis-induced immune modulation: a new frontier in glioblastoma therapy.Naunyn-Schmiedeberg's archives of pharmacology · 2026
    Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review

58 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 8 institutions in 2 countries.

Haizhen Long *National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Liwei Zhang *National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Mengjie Lv *Key Laboratory of Infection and Immunity, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Zengqi Wen *National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Wenhao ZhangMinistry of Education (MOE) Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing, China.
Xiulan ChenUniversity of Chinese Academy of Sciences, Beijing, China.
Peitao ZhangDepartment of Cell Biology, Tianjin Medical University, Tianjin, China.
Tongqing LiCenter for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Luyuan ChangNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Caiwei JinUniversity of Chinese Academy of Sciences, Beijing, China.
Guozhao WuNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Xi WangDepartment of Immunology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
Fuquan YangUniversity of Chinese Academy of Sciences, Beijing, China.
Jianfeng PeiCenter for Quantitative Biology, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
Ping ChenNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Raphael MargueronInstitut Curie, PSL Research University, Paris, France.
Haiteng DengMinistry of Education (MOE) Key Laboratory of Bioinformatics, School of Life Sciences, Tsinghua University, Beijing, China.
Mingzhao ZhuUniversity of Chinese Academy of Sciences, Beijing, China. zhumz@sun5.ibp.ac.cn.
Guohong LiNational Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China. liguohong@sun5.ibp.ac.cn.
Chinese Academy of Sciences · CNUniversity of Chinese Academy of Sciences · CNInstitute of Biophysics · CNPeking University · CNTsinghua University · CNCapital Medical University · CNInstitut Curie · FRTianjin Medical University · CN

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

DNA replication is a tightly regulated process that ensures the precise duplication of the genome during the cell cycle

Indexed as

DNA ReplicationDNA Replication TimingDNAEpigenesis, GeneticHeLa CellsHistone-Lysine N-MethyltransferaseHistonesHumansLysineMethylationNucleosomesOrigin Recognition ComplexReplication OriginDNAhistone H2A.F-ZHistone-Lysine N-MethyltransferaseHistonesKMT5C protein, humanLysineNucleosomesORC1 protein, humanOrigin Recognition Complex

Identifiers

PMID31875854
OpenAlexW2997637122

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.